Abstract

Objective.Determine the frequency of occurrence of tyrosine kinase expression of the mutated ALK and TAG-72 gene among patients with primary melanoma of the skin, to identify their association with a number of histological parameters, and to assess the diagnostic value of the determination of ALK and TAG-72.Materials and methods.Paraffin blocks with surgical material from 40 patients with primary skin melanoma. For routine histological examination, the material was fixed with 10 % neutral formalin for 24 h, poured into paraffin, sections were prepared with a thickness of 4–5 μm, stained with hematoxylin and eosin. IHC study with monoclonal antibodies D57.3 to ALK was performed on an immunostender – Ventana, with antibodies B72.3 to TAG-72 – on Thermo Fischer. As a detection system used: Envision – for TAG-72 and Ventana – for ALK.Results.ALK mutation was detected in 7 (12 %), TAG-72 – 4 (10 %) cases. Evaluation of the correlation force between the presence of ALK and TAG-72 showed a direct average coupling strength (correlation coefficient was 0.31). A direct correlation of the mean force between the presence of TAG-72 oncoprotein, ALK mutation and ulceration in the patient was found – the correlation coefficient was 0.53 and 0.68, respectively. There was a statistically significant association between the presence of ALK and lymphoid infiltration, which in most cases (57 %) was pronounced (p <0.05).Conclusion.Comparing the positive sign of the expression of ALK – 17.5 % and TAG-72 – 10 %, and the positive of their simultaneous detection – 7.5 %, it can be concluded that further studies to determine their diagnostic value are promising. The presence of severe lymphoid infiltration in ALK-positive patients claims a diagnostic value in primary skin melanoma.

Highlights

  • Paraffin blocks with surgical material from 40 patients with primary skin melanoma

  • Comparing the positive sign of the expression of ALK – 17.5 % and Tumor associated protein-72 (TAG-72) – 10 %, and the positive of their simultaneous detection – 7.5 %, it can be concluded that further studies to determine their diagnostic value are promising

  • The presence of severe lymphoid infiltration in ALK-positive patients claims a diagnostic value in primary skin melanoma

Read more

Summary

Оригинальные статьи

ЧАСТОТА ЭКСПРЕССИИ ТИРОЗИНКИНАЗЫ ГЕНА ALK И ОНКОБЕЛКА TAG-72 ПРИ ПЕРВИЧНОЙ МЕЛАНОМЕ КОЖИ. А. Рябчиков4 1ГБУЗ «Московский клинический научный центр ДЗМ»; Россия, 111123 Москва, ш. Пирогова» Минздрава России; Россия, 117997 Москва, ул. Блохина» Минздрава России; Россия, 115478 Москва, Каширское ш., 24. Цель исследования – определить частоту экспрессии тирозинкиназы мутированного гена ALK и онкобелка TAG-72 у пациентов с первичной меланомой кожи, определить их связь с рядом гистологических параметров и оценить диагностическую ценность определения ALK и TAG-72. ALK-мутация была обнаружена в 7 (12 %), TAG-72 – в 4 случаях из 40. Была выявлена прямая связь средней силы между наличием у пациента онкомаркера TAG-72, мутации ALK и изъязвлением – коэффициент корреляции составил 0,53 и 0,68 соответственно. Наличие выраженной лимфоидной инфильтрации у ALK-позитивных пациентов претендует на диагностическое значение при первичной меланоме кожи. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia; 24 Kashirskoe Shosse, Moscow 115478, Russia

Objective
РОССИЙСКИЙ БИОТЕРАПЕВТИЧЕСКИЙ ЖУРНАЛ Russian journal of biotherapy
Findings
Нижняя конечность
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.